Login

The CEO of Freenet AG discusses the company's strategic ambitions in an interview 00:10:00

Share On Facebook Share On Twitter

Christoph Vilanek is Chairman-Mgmt Board/CEO at freenet AG.

Recent Videos

00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio

Suggestions

00:10:00
The preeminent team of experts driving your remarkable success today and beyond|Robert R. Lowther,President,The Denali Group
00:10:00
Wise CEO Kristo Käärmann on Tapping into the Untapped 97% of Global Transfers | Kristo Käärmann ,CEO , Wise Plc.
00:10:00
Fran Horowitz on Revitalizing Abercrombie & Fitch: A Customer-Centric Approach | Fran Horowitz, CEO , Abercrombie & Fitch Co.
00:10:00
Health & Wealth: Aligning Personal Well-being with Financial Planning
00:10:00
Optimizing Efficiency: Vertimill Predictive Analytics by Scott Schemmel & Jolene Baker of Ciner Resources | Kirk Milling, CEO of Ciner Resources LP
00:10:00
Schizophrenia Assessment: Monitoring Symptoms, Treatment, and Side Effects
00:10:00
Real-Life Financial Success: A Client Story by Hyden Ross | Hyden Ross, Director, Pathway Financial Planners.
00:10:00
Exceptional products that exceed our clients’ expectations|Yasuhiro Yokota,President,Tokio Marine Asset Management (USA) Ltd.
00:10:00
The CEO of Learning Technologies Group plc discusses the company's impressive growth and transition from SPAC to public listing.
00:10:00
US Gold Corp CEO George Bee speaks to Proactive's Thomas Warner at Resourcing Tomorrow 2023, Europe's largest mining event in London.|George Bee is CEO of US Gold Corp
00:10:00
Hannon Armstrong CEO Jeffrey Eckel discusses sustainability and clean energy investment strategies on CNBC’s Global Business and Financial News.
00:10:00
F&C Lecture: Navigating Alternative Investments | Paul Niven, Manager, F&C Investment Trust

© 2026 Nehu